2024 : 9 : 8
Mohammad Karimian

Mohammad Karimian

Academic rank: Assistant Professor
ORCID:
Education: PhD.
ScopusId:
HIndex: 0/00
Faculty: Science
Address: Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar 47416-95447, Iran.
Phone: 01135302401

Research

Title
Stem cell therapy as a promising approach for ischemic stroke treatment
Type
JournalPaper
Keywords
Ischemic stroke, Neuron, Chemical drugs, Stem cell therapy
Year
2024
Journal Current Research in Pharmacology and Drug Discovery
DOI
Researchers sahar yaghoi ، Mohammad Karimian

Abstract

Ischemia as the most common type of stroke is the main cause of death and disability in the world. However, there are few therapeutic approaches to treat ischemic stroke. The common approach to the treatment of ischemia includes surgery-cum-chemical drugs. Surgery and chemical drugs are used to remove blood clots to prevent the deterioration of the nervous system. Given the surgical hazards and the challenges associated with chemical drugs, these cannot be considered safe approaches to the treatment of brain ischemia. Besides surgerycum-chemical drugs, different types of stem cells including mesenchymal stem cells and neurological stem cells have been considered to treat ischemic stroke. Therapeutic approaches utilizing stem cells to treat strokes are promising because of their neuroprotective and regenerative benefits. However, the mechanisms by which the transplanted stem cells perform their precisely actions are unknown. The purpose of this study is to critically review stem cell-based therapeutic approaches for ischemia along with related challenges.